FDA Inspection 1289866 - Primus Pharmaceuticals, Inc. - July 23, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Primus Pharmaceuticals, Inc.

Record Details

This FDA Inspection record concerns Primus Pharmaceuticals, Inc., with an inspection on July 23, 2026, issued by the Denver District Office, covering human drugs.

Company: Primus Pharmaceuticals, Inc.
Inspection Date: July 23, 2026
Product Type: Human Drugs
Office: Denver District Office

Open in Dashboard

ID · 39dbcc97-e845-44b0-af6c-26a126e3a1e6

Violation Codes1

21 CFR 314.80(b)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Primus Pharmaceuticals, Inc.July 23, 2026